MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore Charcot-Marie-Tooth disease type 2A2B, its genetic intricacies, and how genetic testing helps in diagnosis, treatment, and family planning strategies.
Explore the role of genetic testing in diagnosing Chitayat syndrome, a rare genetic disorder, to facilitate early intervention and informed family planning.
Uncover PFIC5's genetic roots and the vital role of genetic testing in diagnosis, personalized treatment, and family planning for improved liver health.
Uncover the role of genetic testing in diagnosing and managing COMMA-D. Early diagnosis, personalized treatments, and informed genetic counseling await.
Unlock the potential of genetic testing for early diagnosis and personalized treatment of Congenital Bile Acid Synthesis Defect 6, improving patient outcomes.
Unlock the potential of genetic testing in diagnosing CDG-IAA, a rare disorder, with insights on early diagnosis, family planning, and future therapies.
Explore the role of genetic testing in diagnosing congenital muscular dystrophy syndrome. Learn about early diagnosis, personalized treatment, and family planning.
CMS20, caused by RAPSN gene mutations, leads to muscle weakness. Genetic testing aids diagnosis, personalized treatment, family planning, and research advancements.